Posts
April 15 2025
Can-Fite Biopharma Ltd. announced the closing of its Registered Direct Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
April 14 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Immunic, Inc. announced the closing of its Registered Direct Offering in the amount of $5,100,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,100,000. EG&S acted as counsel to the Placement Agent.
April 09 2025
Titan Acquisition Corp. announced the closing of its initial public offering in the amount of $276,000,000. EGS acted as counsel to the underwriter.
April 07 2025
NeuroOne Medical Technologies Corporation announced the closing of its Underwritten Public Offering in the amount of $8,000,000. EG&S acted as counsel to the Underwriter.
April 07 2025
Mobix Labs, Inc. announced the closing of its Registered Direct Offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
April 04 2025
Aptevo Therapeutics Inc. announced the closing of its Registered Direct Offering and concurrent Private Placement in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.